GLOBALT Investments LLC GA lowered its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 3.0% in the 2nd quarter, Holdings Channel reports. The fund owned 2,921 shares of the financial services provider’s stock after selling 89 shares during the period. GLOBALT Investments LLC GA’s holdings in CME Group were worth $805,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of CME. Wayfinding Financial LLC bought a new position in shares of CME Group during the first quarter worth about $25,000. Webster Bank N. A. grew its position in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC grew its position in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its position in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Raymond James Financial lowered their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. UBS Group decreased their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research report on Thursday. Barclays decreased their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Finally, Piper Sandler increased their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Eight research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $284.53.
Insider Activity
In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.
CME Group Price Performance
Shares of NASDAQ CME opened at $269.54 on Friday. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $97.14 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 6.18 and a beta of 0.41. The firm has a 50-day moving average of $266.47 and a two-hundred day moving average of $271.67.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the company earned $2.68 EPS. CME Group’s revenue was down 3.0% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is currently 48.45%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Retail Stocks Investing, Explained
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Pros And Cons Of Monthly Dividend Stocks
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- How to Short a Stock in 5 Easy StepsĀ
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
